Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz upgrades Rigel Pharmaceuticals (NASDAQ:RIGL) from Neutral to Buy.

Keybanc Maintains Overweight on Dycom Industries, Raises Price Target to $115

By Benzinga Newsdesk

Today, 4:42 AM

Keybanc analyst Sean Eastman maintains Dycom Industries (NYSE:DY) with a Overweight and raises the price target from $104 to $115.

Tesla Upgraded To Buy: Why This Analyst Thinks EV Maker’s Operational Outlook Is Stronger Than Ever

By Shanthi Rexaline

Today, 4:42 AM

Tesla, Inc. (NASDAQ: TSLA) shares have shed more than 30% in the year-to-date period amid worries concerning the COVID-19 lockdowns in China and worsening macroeconomic fundamentals.

TSLA

26 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 4:42 AM

AEI

Analyst Ratings

Analyst Ratings For Magnolia Oil & Gas

By Benzinga Insights

Today, 4:42 AM

Over the past 3 months, 9 analysts have published their opinion on Magnolia Oil & Gas (NYSE:MGY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

MGY

Citigroup Upgrades Rigel Pharmaceuticals to Buy

Related Posts

Keybanc Maintains Overweight on Dycom Industries, Raises Price Target to $115

Tesla Upgraded To Buy: Why This Analyst Thinks EV Maker’s Operational Outlook Is Stronger Than Ever

26 Stocks Moving in Thursday’s Pre-Market Session

Analyst Ratings For Magnolia Oil & Gas